New Study Finally Uncovers the Molecular Trigger Behind Rare COVID Vaccine Blood Clots

Scientists have identified the precise molecular trigger behind a rare blood-clotting disorder linked to certain adenovirus-based COVID-19 vaccines and, in rare cases, natural adenovirus infection. Researchers led by Flinders University, working with international collaborators, have clarified how a rare blood clotting disorder can develop after certain COVID-19 adenovirus-based vaccines or following a natural adenovirus infection. […] Read More